核心新品产业化进展顺利。新签CMP装备订单中先进制程的订单已实现较大占比，部分先进制程CMP 装备在国内多家头部客户实现全部工艺验证，全新抛光系统架构CMP机台Universal-H300已经获得批量 重复订单。12英寸超精密晶圆减薄机Versatile–GP300晶圆减薄的极限厚度及TTV均已达到国际先进水 平，累计出机突破20台。华海清科已实现面向芯片制造的大束流离子注入机各型号的全覆盖，12英寸大 束流离子注入机批量交付国内多家集成电路制造头部企业。 盈利预测：公司深度绑定国内头部客户，核心产品产业化进展顺利，同时考虑到部分产品处于市场开拓 阶段且持续加码研发投入与生产能力建设，我们调整此前业绩预测（2025.7.3）。预计公司2025-2027年 营收分别为45.36/60.15/75.02亿元（前值为45.03/58.60/73.60亿元），归母净利润分别为12.01/16.01/20.13 亿元（前值为12.90/16.90/21.21亿元）。维持"强烈推荐"评级。 十五五规划半导体自主可控提速，先进制造全产业链或迎快速发展期，国产半导体设备与存储客户共同 研发，加速国产化率的提升，当前我们看国内 ...

Core Insights - The AI chip industry has seen a continuous increase in prosperity since 2025, with high investment levels in the semiconductor equipment sector [1] - Global semiconductor equipment company revenues are projected to grow by 12% year-on-year in 2025, with a 24% increase in Q2 2025 [1] - The demand for high-performance SoC testing machines and storage testing machines has significantly increased due to the complex requirements of AI chips [1] - The overseas semiconductor equipment market has experienced a 40% year-on-year growth driven by AI-related investments, particularly in testing and packaging equipment [1] - In contrast, the Chinese market saw a slight decline of 1% year-on-year in H1 2025, although the domestic semiconductor equipment localization rate increased by 6 percentage points to 21% [1] Company Performance - In H1 2025, several semiconductor equipment manufacturers showed varied performance, with nine front-end equipment companies achieving revenue growth [2] - Notable companies with the highest net profit growth include Weidou Nano (348.95%), Changchuan Technology (98.73%), Huafeng Measurement Control (74.04%), and Zhongke Fei Measurement (73.01%) [3] - Leading companies like Beifang Huachuang and Zhongwei Company reported net profit growth rates of 14.97% and 36.62%, respectively [3] - Huahai Qingke recorded a revenue of 1.95 billion yuan, a 30.28% increase, but its net profit growth was lower at 16.82%, indicating a decline in profitability [3] Product Development - Huahai Qingke's main product, CMP equipment, has seen continuous upgrades, with the Universal-H300 polishing system receiving bulk orders [4] - The company has achieved a high market share for its 12-inch and 8-inch CMP equipment among leading domestic clients [4] - The 12-inch ultra-precision wafer thinning machine, Versatile-GP300, has gained market recognition, leading to a significant increase in orders [4] - The company is expanding its wafer regeneration capacity with a project in Kunshan, aiming for a total capacity of 400,000 pieces per month [4]

Core Viewpoint - The company, Huahai Qingke, reported steady growth in revenue and profit for Q2 2025, maintaining high gross and net profit margins, with significant contributions from advanced process CMP equipment orders and successful progress in new product developments [1][2]. Financial Performance - In H1 2025, the company achieved revenue of 1.95 billion yuan, a year-on-year increase of 30.3%, and a net profit attributable to shareholders of 510 million yuan, up 16.8%. The growth in profit was slower than revenue due to rising employee compensation and the impact of the acquisition of Chipwave, alongside increased expense ratios and reduced interest income and government subsidies [1]. - For Q2 2025, revenue reached 1.04 billion yuan, representing a year-on-year increase of 27% and a quarter-on-quarter increase of 13.7%. The gross margin was 45.8%, up 0.9 percentage points year-on-year but down 0.5 percentage points quarter-on-quarter. The net profit attributable to shareholders was 270 million yuan, up 18% year-on-year and 16.5% quarter-on-quarter [1]. Product Development and Orders - The company saw a significant increase in orders for advanced process CMP equipment, with the new polishing system Universal-H300 receiving bulk repeat orders, achieving scale production. Advanced process CMP equipment orders accounted for a large proportion of new orders, with successful verification from several leading domestic clients [2]. - The self-developed 12-inch low-temperature ion implanter iPUMA-LT was delivered to a leading domestic logic chip fab, achieving full coverage of advanced process chip models. The company is also expanding its wafer regeneration capacity, with a planned total capacity of 400,000 pieces per month [2]. Investment Recommendations - The company is expected to maintain steady revenue growth and high profitability levels, with a significant proportion of new CMP equipment orders coming from advanced processes and substantial growth in orders for thinning machines. The progress of new products, including ion implanters, is also promising. Future revenue and net profit projections for 2025, 2026, and 2027 are anticipated to be strong, with corresponding PE ratios reflecting positive market sentiment [3].

Core Insights - The company, Huahai Qingshi (688120), reported a revenue of 1.95 billion yuan for the first half of 2025, representing a year-on-year growth of 30.28% [1] - The net profit attributable to shareholders reached 505 million yuan, an increase of 16.82% year-on-year, while the net profit excluding non-recurring items was 460 million yuan, up 25.02% [1] - The basic earnings per share stood at 2.14 yuan [1] Business Performance - The company's core product matrix showed strong performance, particularly in CMP equipment, which has seen significant technological advancements and market expansion [2] - The new CMP polishing system, Universal-H300, has received bulk repeat orders and achieved large-scale shipments [2] - Advanced process CMP equipment orders have increased significantly, with successful process validation at several leading domestic clients [2] Product Development - The company has developed thinning equipment suitable for advanced packaging and front-end wafer manufacturing, achieving substantial results during the reporting period [2] - The 12-inch ultra-precision wafer thinning machine, Versatile-GP300, saw a significant increase in order volume due to its excellent performance [2] - The 12-inch wafer thinning and film application integrated machine, Versatile-GM300, has been successfully adopted by major domestic semiconductor companies [2] Ion Implantation Equipment - The company’s subsidiary, Xinyu, successfully delivered its first 12-inch low-temperature ion implanter, iPUMA-LT, to a leading domestic logic chip manufacturer [3] - The company is expanding its product matrix to include medium and high-energy ion implanters to meet diverse manufacturing needs [3] Platform Strategy and R&D Investment - The "equipment + service" platform strategy is showing results, with an increase in the scale of key consumables and maintenance services as CMP equipment market share grows [3] - The company’s wafer regeneration business has received bulk orders from major production lines, with a project in Kunshan aiming for a monthly capacity of 200,000 wafers [3] - R&D investment reached 246 million yuan in the first half of 2025, a year-on-year increase of 40.44%, with R&D expenses accounting for 12.63% of revenue [3]